Loading...
01/09 22:53
Loading...
Medtronic PLC (MDT) is set to release its FY2025Q4 earnings performance on 05/21 04:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 8.83B and an earnings per share (EPS) of 1.58 for the FY2025Q4. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings forecast suggests a Beat due to strong performance in core segments supported by clinical data and strategic approvals.
Fact Data Analysis vs. Key Market Concerns:
Positive clinical outcomes for Affera technologies (Sphere-360 and Sphere-9 catheters) presented at HRS 2025 highlight strong demand and efficacy in AFib treatment. This supports sustained growth in this segment.
FDA approval for OmniaSecure defibrillation lead adds to Medtronic’s cardiac portfolio, enhancing competitive positioning.
SmartGuard algorithm partnership with Abbott for interoperable insulin pumps expands Medytocin’s diabetes care ecosystem, driving adoption and cross-selling.
Leadership in leadless pacing (e.g., SMART Trial results for Evolut TAVR) reinforces confidence in continued innovation-driven growth.
Expand URO IDE study success ( 98.5% surgical success rate) strengthens urology robotics offerings, opening new revenue streams.
Potential tariff exemptions in China for medical equipment could reduce supply chain costs and improve margins.
FDA recall of embolization devices (Neurovascular segment) introduces minor downside risk, but core segments remain unaffected.
Operational efficiencies from new product launches (e.g., OmniaSecure lead, Affera catheters) likely offset inflationary pressures.
Rationale: Fact data supports segment-specific outperformance, while consensus expectations remain muted (flat EPS revisions). The stock’s underperformance vs. S&P 500 (-3.47%) creates asymmetric upside if growth drivers materialize.
The earnings call summary reveals positive financial performance with growth in key segments and improved margins. Despite some declines, overall growth in revenue and EPS exceeded expectations. The Q&A section highlights management's confidence in product launches and strategic investments, though some details were vague. The raised guidance and strong pipeline, particularly in cardiovascular and neuroscience, indicate positive sentiment. The combination of these factors suggests a positive stock price movement over the next two weeks.
Medtronic PLC (MDT) is scheduled to release its FY2025Q4 earnings report onMay 21, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 8.83B in revenue and an EPS of 1.58 for Medtronic PLC's FY2025Q4.
Intellectia's exclusive AI algorithms forecast a Beat forMedtronic PLC's FY2025Q4 earnings, with a prediction date of May 21, 2025. Medtronic PLC The earnings forecast suggests a Beat due to strong performance in core segments supported by clinical data and strategic approvals.
Leverage Intellectia's AI forecast to position trades ahead of theMay 21, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!
